Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Modified-release HPMC-AS based tablets fabricated by FDM 3D printing

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: BUANZ, Asma (University College London, UCL School of Pharmacy, London, United Kingdom)
  • Co-author(s): Alvaro Goyanes: FabRx Ltd, Kent, United Kingdom
    Fabrizio Fina: UCL School of Pharmacy, University College London, London, United Kingdom
    Annalisa Martorana: UCL School of Pharmacy, University College London, London, United Kingdom
    Asma Buanz: UCL School of Pharmacy, University College London, London, United Kingdom
    Simon Gaisford: UCL School of Pharmacy, University College London, London, United Kingdom;, FabRx Ltd, Kent, United Kingdom
    Abdul Basit: UCL School of Pharmacy, University College London, London, United Kingdom;, FabRx Ltd, Kent, United Kingdom
  • Abstract:

    Backgrounds

    3D printing (3DP) offers the potential to revolutionise the future production of drug delivery systems. In fused-deposition modelling (FDM) printing, a polymer is heated and extruded through a small tip and solidified on a build plate to create an object. FDM technology can be used to print patient-tailored dose formulations with..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses